Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.28

€1.28

3.010%
0.04
3.010%
€4.15
 
23.04.24 / Tradegate WKN: A2ALP6 / Symbol: CLSD / Name: Clearside / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Clearside Biomedical Inc Stock

A very strong showing by Clearside Biomedical Inc today, with an increase of €0.040 (3.010%) compared to yesterday's price.
Based on 8 Buy predictions and 6 Sell predictions the sentiment towards Clearside Biomedical Inc is rather balanced.
Based on the current price of 1.28 € the target price of 4 € shows a potential of 212.5% for Clearside Biomedical Inc which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Clearside Biomedical Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Clearside Biomedical Inc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 0.00%
Target price 3.723
Change
Ends at 11.04.25

Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -19.50%
Target price 3.656
Change
Ends at 13.03.25

Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $5.00.
Ratings data for CLSD provided by MarketBeat
Show more

Clearside Biomedical, Inc. (NASDAQ: CLSD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CLSD provided by MarketBeat
Show more